Perhaps time for Starpharma to actually do something with DEP Remdesivir and Gilead instead of just 'chatting'
https://www.medpagetoday.com/infectiousdisease/covid19/90008
NIH Guidelines Shrink Scope of Remdesivir Use in COVID-19
— Only dexamethasone now listed for sickest patients
Updated National Institutes of Health guidelines narrowed the scope of recommended use for remdesivir (Veklury) in hospitalized COVID-19 patients, and the quality of evidence backing the drug's use also took a hit.
Perhaps time for Starpharma to actually do something with DEP...
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $45.32M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 11.0¢ | $9.903K | 89.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27588 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 161625 | 8 |
View Market Depth
| Last trade - 16.10pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
11.3¢ |
Change
-0.005 ( 0.54 %) |
||||
| Open | High | Low | Volume | ||
| 11.0¢ | 11.5¢ | 11.0¢ | 15709 | ||
| Last updated 15.58pm 03/06/2024 ? | |||||
| SPL (ASX) Chart |